Deltec Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-72,290
| Closed | -$4.47M | – | 246 |
|
|
2022
Q3 | $4.47M | Sell |
72,290
-14,280
| -16% | -$884K | 1.1% | 19 |
|
|
2022
Q2 | $6.91M | Buy |
86,570
+39,100
| +82% | +$3.12M | 1.62% | 15 |
|
|
2022
Q1 | $4.99M | Sell |
47,470
-18,840
| -28% | -$1.98M | 0.85% | 30 |
|
|
2021
Q4 | $7.15M | Sell |
66,310
-440
| -0.7% | -$47.4K | 1.16% | 25 |
|
|
2021
Q3 | $7.31M | Sell |
66,750
-77,850
| -54% | -$8.53M | 1.1% | 22 |
|
|
2021
Q2 | $13.5M | Hold |
144,600
| – | – | 1.86% | 11 |
|
|
2021
Q1 | $13.3M | Sell |
144,600
-3,000
| -2% | -$276K | 1.98% | 11 |
|
|
2020
Q4 | $10.8M | Buy |
147,600
+50,100
| +51% | +$3.66M | 1.65% | 12 |
|
|
2020
Q3 | $7.57M | Buy |
+97,500
| New | +$7.57M | 1.35% | 17 |
|
|
2018
Q3 | – | Sell |
-21,400
| Closed | -$354K | – | 193 |
|
|
2018
Q2 | $354K | Sell |
21,400
-300
| -1% | -$4.96K | 0.07% | 142 |
|
|
2018
Q1 | $308K | Sell |
21,700
-12,000
| -36% | -$170K | 0.06% | 154 |
|
|
2017
Q4 | $492K | Sell |
33,700
-100,000
| -75% | -$1.46M | 0.1% | 123 |
|
|
2017
Q3 | $1.7M | Sell |
133,700
-109,000
| -45% | -$1.38M | 0.34% | 72 |
|
|
2017
Q2 | $2.89M | Buy |
242,700
+46,922
| +24% | +$558K | 0.59% | 64 |
|
|
2017
Q1 | $2.89M | Buy |
195,778
+50,078
| +34% | +$740K | 0.59% | 63 |
|
|
2016
Q4 | $2.36M | Sell |
145,700
-46,150
| -24% | -$747K | 0.55% | 59 |
|
|
2016
Q3 | $3.48M | Buy |
191,850
+27,450
| +17% | +$498K | 0.79% | 43 |
|
|
2016
Q2 | $2.71M | Hold |
164,400
| – | – | 0.68% | 44 |
|
|
2016
Q1 | $2.72M | Buy |
164,400
+154,400
| +1,544% | +$2.56M | 0.68% | 43 |
|
|
2015
Q4 | $217K | Hold |
10,000
| – | – | 0.06% | 130 |
|
|
2015
Q3 | $198K | Buy |
+10,000
| New | +$198K | 0.05% | 156 |
|